SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001840051-22-000001
Filing Date
2022-05-23
Accepted
2022-05-20 21:13:27
Documents
1
Effectiveness Date
2022-05-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10725
  Complete submission text file 0001840051-22-000001.txt   11755
Mailing Address 275 BAYSHORE BLVD, UNIT 1607 TAMPA FL 33606
Business Address 275 BAYSHORE BLVD, UNIT 1607 TAMPA FL 33606 858-480-2404
InflammX Therapeutics, Inc. (Filer) CIK: 0001840051 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-446531 | Film No.: 22949414